Cancer Death Rate Continuing to Decline in United States

Share this content:
Cancer Death Rate Continuing to Decline in United States
Cancer Death Rate Continuing to Decline in United States

FRIDAY, Jan. 5, 2018 (HealthDay News) -- In both men and women in the United States, the cancer death rate declined by about 1.5 percent annually from 2006 to 2015, according to a study published online Jan. 4 in CA: A Cancer Journal for Clinicians.

Rebecca L. Siegel, M.P.H., from the American Cancer Society in Atlanta, and colleagues estimated the number of new cancer cases and deaths that will occur in the United States in 2018. Incidence and mortality data were obtained through 2014 and 2015, respectively.

The researchers project that 1,735,350 new cancer cases and 609,640 cancer deaths will occur in the United States in 2018. The cancer incidence rate was stable in women from 2005 to 2014 and decreased by about 2 percent annually in men. The cancer death rate decreased by about 1.5 percent annually for men and women from 2006 to 2015. From 1991 to 2015 there was a continuous decrease of 26 percent in the combined cancer death rate, resulting in about 2,378,600 fewer cancer deaths than would have been expected if death rates had stayed at their peak. From 2014 to 2015, of the 10 leading causes of death, only cancer declined. The cancer death rate was 14 percent higher in non-Hispanic blacks than non-Hispanic whites; the racial disparity was larger for those aged <65 years (death rate ratio, 1.31) than those aged ≥65 years (death rate ratio, 1.07).

"Larger racial inequalities in young and middle-aged adults probably partly reflect less access to high-quality health care," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Deep Learning-Enhanced Device Detects Diabetic Retinopathy

Deep Learning-Enhanced Device Detects Diabetic Retinopathy

Device sensitivity/specificity 100/97.8 percent for vision-threatening diabetic retinopathy

Altered Gut Microbiome Seen in Patients With Active Lupus

Altered Gut Microbiome Seen in Patients With Active ...

Patients with lupus had fivefold greater representation of Ruminococcus gnavus

Combo Regimens Effective for Tx of Metastatic Renal Cell Cancer

Combo Regimens Effective for Tx of Metastatic Renal ...

Two large trials show benefits for pembrolizumab-axitinib and avelumab-axitinib versus sunitinib

is free, fast, and customized just for you!




Already a member?

Sign In Now »